A critical discovery in cancer research is emerging with the use of mini-antibodies to re-engage mutated p53. This vital cancer inhibitor protein is frequently disabled in several kinds of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research